Enjamb Labs
YC X26San Francisco, US · Founded 2025 · 2 employees · 1 known investors
Enjamb develops an agentic AI platform for biopharma R&D teams that automates drug discovery, trial execution, and regulatory filings. The platform integrates with existing systems to support programs from early discovery through FDA approval.
Also known as Enjamb · Enjamb Labs Inc
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSB2BAutomationAIUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (X26)
Enjamb Labs was founded in 2025 by Rayan Mubarak and Maadhav Deekshitha.
RM
Rayan Mubarakin𝕏CEO, FounderRayan Mubarak has published machine learning and biology research, including work on cancer detection models and drug therapeutics for pesticide poisoning. His research has been presented at major bioscience conferences.
MD
Maadhav Deekshithain𝕏Founder/CTOMaadhav worked as an engineer at Dell's AI Lab on CPU optimization for supercomputing infrastructure, and at Broadcom R&D developing AI ASICs.
Investors · 1
In the news
Frequently asked questions
- What does Enjamb Labs do?
- Enjamb develops an agentic AI platform for biopharma R&D teams that automates drug discovery, trial execution, and regulatory filings. The platform integrates with existing systems to support programs from early discovery through FDA approval.
- Who founded Enjamb Labs?
- Enjamb Labs was founded by Rayan Mubarak, Maadhav Deekshitha in 2025.
- Who are Enjamb Labs's investors?
- Enjamb Labs's investors include Y Combinator.
- Where is Enjamb Labs headquartered?
- Enjamb Labs is headquartered in San Francisco, US.